JP2003154241A - Method and apparatus for dissolving solid chemical - Google Patents

Method and apparatus for dissolving solid chemical

Info

Publication number
JP2003154241A
JP2003154241A JP2001357757A JP2001357757A JP2003154241A JP 2003154241 A JP2003154241 A JP 2003154241A JP 2001357757 A JP2001357757 A JP 2001357757A JP 2001357757 A JP2001357757 A JP 2001357757A JP 2003154241 A JP2003154241 A JP 2003154241A
Authority
JP
Japan
Prior art keywords
solid
medicine
concentration
drug
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001357757A
Other languages
Japanese (ja)
Other versions
JP3759583B2 (en
Inventor
Akira Iimura
晶 飯村
Masaaki Amano
正紹 天野
Kazuhiko Tsunoda
和彦 角田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kurita Water Industries Ltd
Original Assignee
Kurita Water Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurita Water Industries Ltd filed Critical Kurita Water Industries Ltd
Priority to JP2001357757A priority Critical patent/JP3759583B2/en
Publication of JP2003154241A publication Critical patent/JP2003154241A/en
Application granted granted Critical
Publication of JP3759583B2 publication Critical patent/JP3759583B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Accessories For Mixers (AREA)
  • Treatment Of Water By Oxidation Or Reduction (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a method for dissolving a solid chemical, which enable simple and stable management of the concentration of the solid chemical, and an apparatus. SOLUTION: The solid chemical is stored in a water-permeable vessel 202. A dissolving liquid is supplied to the vessel 202. The solid chemical is dissolved in the supplied dissolving liquid. The solid chemical-containing dissolving liquid is made to flow in a water circulating system 100. The amount of the dissolving liquid to be supplied to the vessel 202 is controlled according to the monitored concentration of the solid chemical in the system 100.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する技術分野】本発明は、主として冷却水系
に用いることができる固型薬剤の溶解方法及び装置に関
する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method and an apparatus for dissolving a solid medicine which can be used mainly in a cooling water system.

【0002】[0002]

【従来の技術】従来、冷却水を循環する循環水系では、
一般に、水処理薬剤が用いられている。このような水処
理薬剤は、冷却水中のスケール、スライム、又は腐食障
害の発生を防止するために用いられている。係る水処理
薬剤には、液体型及び固型のものがある。ここで、液体
型薬剤は、漏洩の問題があり、漏洩対策を施す必要があ
った。また、固型薬剤は、溶解速度が不均一で濃度管理
が難しく、その取り扱いが煩雑であった。
2. Description of the Related Art Conventionally, in a circulating water system for circulating cooling water,
Generally, water treatment agents are used. Such water treatment agents are used to prevent scale, slime, or corrosion damage from occurring in cooling water. Such water treatment agents include liquid type and solid type. Here, the liquid medicine has a problem of leakage, and it is necessary to take measures against leakage. Further, the solid drug had a non-uniform dissolution rate, which made it difficult to control the concentration, and the handling thereof was complicated.

【0003】[0003]

【発明が解決しようとする課題】本発明は、上記事情に
対して、固型薬剤の濃度管理を簡便かつ安定に行うこと
ができるようにした固型薬剤の溶解方法及び装置を提供
することを目的とする。
SUMMARY OF THE INVENTION In view of the above circumstances, the present invention provides a method and apparatus for dissolving a solid drug capable of easily and stably controlling the concentration of the solid drug. To aim.

【0004】[0004]

【課題を解決するための手段】上記目的を達成するため
に、本発明に係る固型薬剤の溶解方法は、透水性の容器
内に固型薬剤を収納し、上記容器内に溶解液を供給し、
供給された溶解液によって固型薬剤を溶解し、固型薬剤
を含む溶解液を循環水系に流入させ、該循環水系中の固
型薬剤濃度を監視し、固型薬剤濃度に応じて、上記容器
への溶解液の供給状態を制御するようにしたことを特徴
とする。ここで、上記固形薬剤濃度の監視手段として
は、酸化還元電位の測定手段を挙げることができる。
In order to achieve the above object, a method for dissolving a solid drug according to the present invention is to store the solid drug in a water-permeable container and supply the solution to the container. Then
The solid drug is dissolved by the supplied dissolution liquid, the dissolution liquid containing the solid drug is caused to flow into the circulating water system, the concentration of the solid drug in the circulating water system is monitored, and the above-mentioned container is determined according to the concentration of the solid drug. It is characterized in that the supply state of the solution to the control unit is controlled. Here, as the means for monitoring the solid drug concentration, a means for measuring the redox potential can be mentioned.

【0005】上記透水性の容器は、網状の部材を用いた
箱型形状として構成したものを用いることが好適であ
る。上記固形薬剤としては、スケール防止剤、防食剤、
スライムコントロール剤、消泡剤のうちいずれか一又は
二以上を用いることが好適である。
As the water-permeable container, it is preferable to use a box-shaped container using a mesh member. As the solid drug, scale inhibitor, anticorrosive,
It is preferable to use one or more of the slime control agent and the defoaming agent.

【0006】また、本発明は、別の側面において、固形
薬剤の溶解装置であり、固型薬剤を収納するための透水
性の容器と、該容器内に溶解液を供給するための溶解液
供給手段と、固定薬剤を含む溶解液が流入する循環水系
中の固型薬剤濃度を監視するための監視手段と、該監視
手段からの情報に基づいて、上記容器への溶解液の供給
状態を制御するための溶解液制御手段とを含むことを特
徴とする。ここで、上記固形薬剤濃度の監視手段として
は、酸化還元電位の測定手段を挙げることができる。
[0006] In another aspect, the present invention is a solid medicine dissolving apparatus, which is a water-permeable container for storing a solid medicine and a solution supply for supplying a dissolving solution into the container. Means, monitoring means for monitoring the concentration of the solid drug in the circulating water system into which the solution containing the fixed drug flows, and controlling the supply state of the solution to the container based on the information from the monitoring means. And a dissolution liquid control means for controlling. Here, as the means for monitoring the solid drug concentration, a means for measuring the redox potential can be mentioned.

【0007】前記した溶解方法と同様、好ましくは、上
記透水性の容器を、網状の部材を用いた箱型形状として
構成する。また、上記固形薬剤としては、スケール防止
剤、防食剤、スライムコントロール剤、消泡剤のうちい
ずれか一又は二以上を設置することが好適である。
Similar to the above-mentioned dissolution method, preferably, the water-permeable container is formed in a box shape using a mesh member. Further, it is preferable to install any one or more of a scale inhibitor, an anticorrosive agent, a slime control agent, and an antifoaming agent as the above-mentioned solid medicine.

【0008】[0008]

【発明の実施の形態】以下に添付図面に示した実施の形
態を参照しながら、本発明に係る固型薬剤の溶解方法及
び装置をさらに詳細に説明する。図1は、本発明に係る
固型薬剤の溶解装置の一実施の形態を含む冷却水の循環
システムを示す。この循環システムは、循環水系本体1
00と、薬剤供給系200とを含んでいる。
BEST MODE FOR CARRYING OUT THE INVENTION The method and apparatus for dissolving a solid medicine according to the present invention will be described in more detail below with reference to the embodiments shown in the accompanying drawings. FIG. 1 shows a cooling water circulation system including an embodiment of a solid medicine dissolving apparatus according to the present invention. This circulation system consists of the circulating water system body 1
00 and a drug supply system 200.

【0009】循環水系本体100は、熱交換器102と
冷却水循環ポンプ104とを含む。循環水系本体100
は、冷却塔106から上記熱交換器102に冷却水を循
環するための冷却水系を構成している。循環する冷却水
によって冷却される対象としては、圧縮式冷凍機、吸収
式冷凍機、コンプレッサー等を挙げることができる。し
かし、特にこれらに限定されるものではない。
The circulating water system body 100 includes a heat exchanger 102 and a cooling water circulating pump 104. Circulating water system body 100
Constitutes a cooling water system for circulating cooling water from the cooling tower 106 to the heat exchanger 102. The object to be cooled by the circulating cooling water may be a compression refrigerator, an absorption refrigerator, a compressor, or the like. However, it is not particularly limited to these.

【0010】薬剤供給系200は、透水性の容器20
2、水中ポンプ204、酸化還元電位計(以下、ORP
計ともいう)206、濃度制御装置208とを含む。
The drug supply system 200 comprises a water-permeable container 20.
2, submersible pump 204, redox electrometer (hereinafter, ORP
206) and a concentration control device 208.

【0011】透水性の容器202は、固型薬剤を収納す
るためのものである。容器202は、一般に、網状の部
材を用いて、箱型形状に構成することが好適である。も
っとも、本発明の目的に反しない限り、円筒状、角柱
状、網袋状等でも良く、箱型状に限定されるものではな
い。また、透水性であれば、網状以外にも、多孔性の部
材であって、設置される固型薬剤が溶解される前に排出
されない部材であれば採用することができる。また、こ
のような部材自体の材質は、設置される固型薬剤によっ
て腐食されない材質で構成する。したがって、設置され
る固型薬剤によって異なるが、一般的には、樹脂、プラ
スチックを用いることが好ましい。
The water-permeable container 202 is for accommodating a solid medicine. It is generally preferable that the container 202 is formed in a box shape by using a mesh member. However, as long as it does not deviate from the object of the present invention, it may be cylindrical, prismatic, net bag-shaped, etc., and is not limited to a box shape. Further, as long as it is water-permeable, a member other than the mesh-like member which is a porous member and which is not discharged before the installed solid medicine is dissolved can be adopted. Further, the material of such a member itself is made of a material that is not corroded by the installed solid chemical. Therefore, it is generally preferable to use resin or plastic, although it depends on the solid medicine to be installed.

【0012】透水性の容器202に設置される固型薬剤
としては、スケール防止剤、防食剤、スライムコントロ
ール剤、消泡剤のうちいずれか一又は二以上である。具
体的には、トリクロロイソシアヌル酸、ジクロロイソシ
アヌル酸ナトリウム等のクロルイソシアヌル酸化合物、
次亜塩素酸カルシウムのいずれか一又は二以上を打錠成
型した固型薬剤が好適である。なお、本発明の目的に反
しない限り、冷却水中のスケール、スライム、又は腐食
障害の発生を防止するために用いられる固型薬剤であれ
ば、これらに限定されるものではなく、また、それぞれ
の薬剤の打錠成型薬剤を混合して使用してもよい。
The solid chemical agent placed in the water-permeable container 202 is any one or more of scale inhibitor, anticorrosive agent, slime control agent, and defoaming agent. Specifically, trichloroisocyanuric acid, chloroisocyanuric acid compounds such as sodium dichloroisocyanurate,
A solid medicine obtained by tableting any one or more of calcium hypochlorite is preferable. In addition, as long as it is not against the object of the present invention, scale in cooling water, slime, or solid agents used to prevent the occurrence of corrosion damage, is not limited to these, and each You may mix and use the tablet-forming medicine of a chemical | medical agent.

【0013】水中ポンプ204は、上記透水性の容器2
02に、溶解液を供給するための溶解液供給手段を構成
する。溶解液は、循環水系本体100によって循環され
る冷却水そのものである。しかし、このように水中ポン
プ204によって供給される溶解液以外に、外部から溶
解液(一般的には水)を供給するようにすることもでき
る。薬剤濃度監視手段としては、使用する薬剤が酸化剤
のものであれば、酸化剤濃度とORPとの関係を把握す
ることにより、ORPにより濃度管理をすることができ
る。
The submersible pump 204 is the water-permeable container 2 described above.
Reference numeral 02 constitutes a solution supply means for supplying a solution. The solution is the cooling water itself circulated by the circulating water system body 100. However, in addition to the dissolution liquid supplied by the submersible pump 204 as described above, a dissolution liquid (generally water) may be supplied from the outside. As the drug concentration monitoring means, if the drug to be used is an oxidizing agent, the concentration can be controlled by the ORP by grasping the relationship between the oxidizing agent concentration and the ORP.

【0014】この意味で、ORP計206は、固型薬剤
を含む溶解液が流入する循環水系中の固型薬剤濃度を監
視するための監視手段を構成する。ORP計206は、
検出部を水系に接触させ、循環水系すなわち、貯留水1
08中の固型薬剤濃度を検出する。本実施の形態では、
ORP計206を用いている。しかし、本発明の目的に
反しない限り、測定対象となる固型薬剤の種類に応じ
て、他にもDPD(N,N−ジエチルフェニレンジアミ
ン)法、ポーラログラフ法等を採用することができ、特
にこれに限定されるものではない。また、場合によって
複数の濃度計を併用することとしても良い。
In this sense, the ORP meter 206 constitutes a monitoring means for monitoring the concentration of the solid drug in the circulating water system into which the solution containing the solid drug flows. The ORP meter 206 is
The detection part is brought into contact with the water system, and the circulating water system, that is, the stored water 1
The solid drug concentration in 08 is detected. In this embodiment,
The ORP meter 206 is used. However, the DPD (N, N-diethylphenylenediamine) method, the polarographic method, and the like can be adopted in addition to the above, depending on the type of the solid drug to be measured, unless the object of the present invention is violated. It is not limited to this. In addition, a plurality of densitometers may be used together depending on the case.

【0015】濃度制御装置208は、ORP計206か
らの情報(検出信号)に基づいて、上記容器202への
溶解液の供給状態を制御するための溶解液制御手段を構
成する。濃度制御装置208は、一般的には、コンピュ
ータ装置であり、ORP計206からの検出信号に基づ
いて、水中ポンプ204に制御信号を送ってその稼動状
態を適正に保つ。濃度制御装置208の構成、それを機
能させるためのソフトウエア、制御の手順等は、本発明
の目的に反しない限り、当業者にとって公知のものを採
用することができる。制御方法としては、フィードバッ
ク制御、フィードフォーワード制御、ファジー制御等、
本発明の目的に反しない限り、当業者にとって公知のも
のを採用することができる。
The concentration control device 208 constitutes a dissolution liquid control means for controlling the supply state of the dissolution liquid to the container 202 based on the information (detection signal) from the ORP meter 206. The concentration control device 208 is generally a computer device, and based on a detection signal from the ORP meter 206, sends a control signal to the submersible pump 204 to maintain its operating state properly. As for the configuration of the concentration control device 208, the software for operating the concentration control device 208, the control procedure, and the like, those known to those skilled in the art can be adopted as long as they do not conflict with the object of the present invention. Control methods include feedback control, feedforward control, fuzzy control, etc.
As long as it is not against the object of the present invention, those known to those skilled in the art can be adopted.

【0016】次に上記構成とした固型薬剤の溶解装置の
一実施の形態を含む冷却水の循環システムについて、そ
の作用を説明することにより、本発明に係る固型薬剤の
溶解方法の一実施の形態を説明する。
Next, the operation of the cooling water circulation system including the embodiment of the solid medicine dissolving apparatus having the above-described structure will be described to explain the solid medicine dissolving method according to the present invention. The form of will be described.

【0017】循環水系本体100では、貯留水108か
ら冷却水循環ポンプ104によって、冷却水を熱交換器
102に送る。熱交換器102では、熱交換を行って、
冷却対象物の冷却を行う。熱交換器102を経た冷却水
は、冷却塔106の上部から冷却塔106内に戻され
る。このような手順を繰り返して、冷却水を循環させて
いる。このような冷却水の循環系では、スケール、スラ
イム、又は腐食障害の発生を防ぐことが必要である。ま
た、冷却塔106の上部には送風機110が設けられ、
冷却塔106内の空気(水蒸気を含む)を排出すること
によって、冷却水を冷却する。
In the circulating water system body 100, cooling water is sent from the stored water 108 to the heat exchanger 102 by the cooling water circulation pump 104. In the heat exchanger 102, heat is exchanged,
The object to be cooled is cooled. The cooling water that has passed through the heat exchanger 102 is returned from the upper part of the cooling tower 106 into the cooling tower 106. By repeating such a procedure, the cooling water is circulated. In such a cooling water circulation system, it is necessary to prevent the occurrence of scale, slime, or corrosion damage. Further, a blower 110 is provided above the cooling tower 106,
The cooling water is cooled by discharging the air (including water vapor) in the cooling tower 106.

【0018】一方、薬剤供給系200では、水中ポンプ
204から、貯留水108の一部を溶解液として、透水
性の容器202に送る。上記したように容器202内に
は、固型薬剤が設置されており、供給された溶解液によ
って、固型薬剤の一部が溶解する。固型薬剤を含む溶解
液は、容器202から送出され、貯留水108の一部と
なる。
On the other hand, in the chemical supply system 200, a part of the stored water 108 is sent as a solution from the submersible pump 204 to the water permeable container 202. As described above, the solid medicine is installed in the container 202, and the supplied dissolution liquid dissolves part of the solid medicine. The solution containing the solid medicine is delivered from the container 202 and becomes a part of the stored water 108.

【0019】ここで、ORP計206によって、貯留水
108の固形薬剤濃度を監視し、検出する。固型薬剤の
濃度信号は、濃度制御装置208に送られる。濃度制御
装置208では、固型薬剤の濃度が設定値に保たれるよ
う、水中ポンプ204の稼動状態を制御する。フィード
バック制御を例に取ると、濃度が高すぎると判断される
場合は、供給水量を減少させ、低すぎると判断される場
合には、供給水量を増加させる等のように制御する。こ
のようにして、固型薬剤の濃度管理を簡便かつ安定に行
うことができ、スケール、スライム、又は腐食障害の発
生を防止することができる。なお、固型薬剤の設定濃度
は、使用する固型薬剤の種類、冷却水自体の性状に応じ
て設定する。
Here, the ORP meter 206 monitors and detects the solid chemical concentration of the stored water 108. The concentration signal of the solid medicine is sent to the concentration controller 208. The concentration control device 208 controls the operating state of the submersible pump 204 so that the concentration of the solid medicine is maintained at the set value. Taking feedback control as an example, when the concentration is judged to be too high, the supply water amount is reduced, and when it is judged to be too low, the supply water amount is increased. In this way, the concentration of the solid drug can be controlled easily and stably, and the occurrence of scale, slime, or corrosion damage can be prevented. The set concentration of the solid medicine is set according to the type of solid medicine used and the properties of the cooling water itself.

【0020】[0020]

【実施例】実施例1,2 以下の条件で、図1に概要を示した装置を用いて、試験
を行った。 冷却塔規模:100RT 固型薬剤:トリクロロイソシアヌル酸ナトリウムを用
いた。 濃度測定方法:ORP計を用いた。 スライム付着量の測定:ゴム板法によった。この方法
では、3cm×5cm×1mmのゴム板を用い、これを
貯留水中にいれ、スライムの付着量を直接測定した。
EXAMPLES Examples 1 and 2 A test was conducted under the following conditions using the apparatus outlined in FIG. Cooling tower scale: 100 RT Solid drug: sodium trichloroisocyanurate was used. Concentration measurement method: An ORP meter was used. Measurement of slime adhesion amount: by a rubber plate method. In this method, a rubber plate having a size of 3 cm × 5 cm × 1 mm was used, and the plate was placed in stored water to directly measure the amount of slime adhered.

【0021】実施例1では、トリクロロイソシアヌル酸
ナトリウムを3kg、箱型網状の透水性の容器202に
充填し、残留塩素濃度が0.3mg/L(ORPで40
0mVに相当する)となるように設定した。循環水系内
の残留塩素濃度の推移を表1に示す。実施例2では、ト
リクロロイソシアヌル酸ナトリウムを6kg、実施例1
と同じ透水性の容器202に充填し、残留塩素濃度0.
3mg/Lとなるように設定した。循環水系内の残留塩
素濃度の推移を表1に示す。表1に示すように、実施例
1,2とも1ケ月間安定して、循環水中に残留塩素濃度
を維持することができ、トリクロロイソシアヌル酸ナト
リウムの濃度を維持することができたことが了解され
る。
In Example 1, 3 kg of sodium trichloroisocyanurate was filled in a box-shaped reticulated water-permeable container 202, and the residual chlorine concentration was 0.3 mg / L (40 in ORP).
(Corresponding to 0 mV). Table 1 shows changes in the residual chlorine concentration in the circulating water system. In Example 2, 6 kg of sodium trichloroisocyanurate, Example 1
The same water-permeable container 202 as above was filled with the residual chlorine concentration of 0.
It was set to be 3 mg / L. Table 1 shows changes in the residual chlorine concentration in the circulating water system. As shown in Table 1, it was understood that both Examples 1 and 2 could stably maintain the residual chlorine concentration in the circulating water and the sodium trichloroisocyanurate concentration for one month. It

【0022】比較例1,2 以下の条件で、図1に概要を示した装置を用いて、試験
を行った。 冷却塔規模:100RT 固型薬剤:トリクロロイソシアヌル酸ナトリウムを用
いた。 濃度測定:濃度制御は行わず、単に固型薬剤を実施例
1と同じ容器に入れ、ピットに浸漬した。 スライム付着量の測定:ゴム板法によった。この方法
では、3cm×5cm×1mmのゴム板を用い、これを
貯留水中にいれ、スライムの付着量を直接測定した。
Comparative Examples 1 and 2 Tests were conducted under the following conditions using the apparatus outlined in FIG. Cooling tower scale: 100 RT Solid drug: sodium trichloroisocyanurate was used. Concentration measurement: The concentration was not controlled, and the solid medicine was simply put in the same container as in Example 1 and immersed in the pit. Measurement of slime adhesion amount: by a rubber plate method. In this method, a rubber plate having a size of 3 cm × 5 cm × 1 mm was used, and the plate was placed in stored water to directly measure the amount of slime adhered.

【0023】比較例1では、トリクロロイソシアヌル酸
ナトリウムを3kg、実施例1と同じ透水性の容器20
2に充填した。循環水系内の残留塩素濃度の推移を表1
に示す。比較例2では、トリクロロイソシアヌル酸ナト
リウムを6kg、実施例1と同じ透水性の容器202に
充填した。循環水系内の残留塩素濃度の推移を表1に示
す。表1に示すように、比較例1,2とも、残留塩素濃
度を安定に維持することはできなかった。
In Comparative Example 1, 3 kg of sodium trichloroisocyanurate and the same water-permeable container 20 as in Example 1 were used.
Filled to 2. Table 1 shows changes in residual chlorine concentration in the circulating water system
Shown in. In Comparative Example 2, 6 kg of sodium trichloroisocyanurate was filled in the same water-permeable container 202 as in Example 1. Table 1 shows changes in the residual chlorine concentration in the circulating water system. As shown in Table 1, in both Comparative Examples 1 and 2, the residual chlorine concentration could not be stably maintained.

【0024】[0024]

【表1】 [Table 1]

【0025】他の実施の形態 本発明に係る固型薬剤の溶解方法及び装置は、上記の実
施の形態について説明したが、本発明は、このような実
施の形態に限定されるものではなく、当業者にとって自
明な修飾・変更・付加は、全て本発明の技術的範囲に含
まれる。例えば、上記図1の実施の形態は、開放循環冷
却水系で用いているが、有機性排ガススクラバー水系で
用いることもできる。
Other Embodiments The method and apparatus for dissolving a solid medicine according to the present invention have been described in the above embodiments, but the present invention is not limited to such embodiments. All modifications, changes and additions that are obvious to those skilled in the art are included in the technical scope of the present invention. For example, although the embodiment of FIG. 1 described above is used in an open circulation cooling water system, it can also be used in an organic exhaust gas scrubber water system.

【0026】[0026]

【発明の効果】上記したところから明らかなように、本
発明によれば、固型薬剤の濃度管理を簡便かつ安定に行
うことができるようにした固型薬剤の溶解方法及び装置
が提供される。
As is apparent from the above, according to the present invention, there is provided a method and an apparatus for dissolving a solid drug, which enables simple and stable concentration control of the solid drug. .

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明に係る固型薬剤の溶解装置の一実施の形
態を含む冷却水の循環システムを説明する概念図であ
る。
FIG. 1 is a conceptual diagram illustrating a cooling water circulation system including an embodiment of a solid medicine dissolving apparatus according to the present invention.

【符号の説明】[Explanation of symbols]

100 循環水系本体 102 熱交換器 104 冷却水循環ポンプ 106 冷却塔 108 貯留水 110 送風機 200 薬剤供給系 202 透水性の容器 204 水中ポンプ 206 酸化還元電位計 208 濃度制御装置 100 Circulating water system body 102 heat exchanger 104 Cooling water circulation pump 106 cooling tower 108 stored water 110 blower 200 drug supply system 202 Water-permeable container 204 Submersible pump 206 Redox potentiometer 208 Concentration control device

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) C02F 1/50 531 C02F 1/50 531P 532 532D 540 540C 550 550L 1/76 1/76 A 5/00 610 5/00 610G 5/06 5/06 5/12 5/12 (72)発明者 角田 和彦 東京都新宿区西新宿三丁目4番7号 栗田 工業株式会社内 Fターム(参考) 4D050 AA08 AB06 BB06 BD03 BD08 4G035 AA25 AE01 4G037 BA05 BC03 BD06 EA10 ─────────────────────────────────────────────────── ─── Continuation of front page (51) Int.Cl. 7 Identification code FI theme code (reference) C02F 1/50 531 C02F 1/50 531P 532 532D 540 540C 550 550L 1/76 1/76 A 5/00 610 5/00 610G 5/06 5/06 5/12 5/12 5/12 (72) Inventor Kazuhiko Kakuda 3-4-7 Nishi-Shinjuku, Shinjuku-ku, Tokyo F-Term (reference) within Kurita Industry Co., Ltd. 4D050 AA08 AB06 BB06 BD03 BD08 4G035 AA25 AE01 4G037 BA05 BC03 BD06 EA10

Claims (6)

【特許請求の範囲】[Claims] 【請求項1】 透水性の容器内に固型薬剤を収納し、 上記容器内に溶解液を供給し、 供給された溶解液によって固型薬剤を溶解し、 固型薬剤を含む溶解液を循環水系に流入させ、 該循環水系中の固型薬剤濃度を監視し、 固型薬剤濃度に応じて、上記容器への溶解液の供給状態
を制御するようにしたことを特徴とする固型薬剤の溶解
方法。
1. A solid medicine is housed in a water-permeable container, a dissolution liquid is supplied to the container, the solid medicine is dissolved by the supplied dissolution liquid, and a dissolution liquid containing the solid medicine is circulated. The solid drug concentration of the solid drug is made to flow into the water system, the concentration of the solid drug in the circulating water system is monitored, and the supply state of the solution to the container is controlled according to the solid drug concentration. Dissolution method.
【請求項2】 固形薬剤濃度の監視手段として酸化還元
電位測定手段を用いることを特徴とする請求項1の固型
薬剤の溶解方法。
2. The method for dissolving a solid drug according to claim 1, wherein an oxidation-reduction potential measuring device is used as the solid drug concentration monitoring device.
【請求項3】 上記固形薬剤として、スケール防止剤、
防食剤、スライムコントロール剤、消泡剤のうちいずれ
か一又は二以上を用いることを特徴とする請求項1又は
2の固型薬剤の溶解方法。
3. The scale medicine as the solid medicine,
The method for dissolving a solid medicine according to claim 1 or 2, wherein any one or more of an anticorrosive agent, a slime control agent, and an antifoaming agent is used.
【請求項4】固型薬剤を収納するための透水性の容器
と、 該容器内に溶解液を供給するための溶解液供給手段と、 固定薬剤を含む溶解液が流入する循環水系中の固型薬剤
濃度を監視するための監視手段と、 該監視手段からの情報に基づいて、上記容器への溶解液
の供給状態を制御するための溶解液制御手段とを含むこ
とを特徴とする固型薬剤の溶解装置。
4. A water-permeable container for containing a solid medicine, a solution supply means for supplying a solution into the container, and a solid solution in a circulating water system into which the solution containing a fixed medicine flows. A solid mold characterized by including monitoring means for monitoring the concentration of the type drug and dissolution liquid control means for controlling the supply state of the dissolution liquid to the container based on information from the monitoring means. Drug dissolution device.
【請求項5】 固形薬剤濃度の上記監視手段として酸化
還元電位測定手段を用いることを特徴とする請求項4の
固型薬剤の溶解装置。
5. The solid medicine dissolving device according to claim 4, wherein a redox potential measuring means is used as the means for monitoring the solid medicine concentration.
【請求項6】 上記固形薬剤として、スケール防止剤、
防食剤、スライムコントロール剤、消泡剤のうちいずれ
か一又は二以上を設置することを特徴とする請求項4又
は5の固型薬剤の溶解方法。
6. The scale medicine as the solid medicine,
The method for dissolving a solid medicine according to claim 4 or 5, wherein any one or more of an anticorrosive agent, a slime control agent, and an antifoaming agent is installed.
JP2001357757A 2001-11-22 2001-11-22 Method and apparatus for dissolving solid drug Expired - Fee Related JP3759583B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001357757A JP3759583B2 (en) 2001-11-22 2001-11-22 Method and apparatus for dissolving solid drug

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001357757A JP3759583B2 (en) 2001-11-22 2001-11-22 Method and apparatus for dissolving solid drug

Publications (2)

Publication Number Publication Date
JP2003154241A true JP2003154241A (en) 2003-05-27
JP3759583B2 JP3759583B2 (en) 2006-03-29

Family

ID=19169052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001357757A Expired - Fee Related JP3759583B2 (en) 2001-11-22 2001-11-22 Method and apparatus for dissolving solid drug

Country Status (1)

Country Link
JP (1) JP3759583B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005246172A (en) * 2004-03-02 2005-09-15 Permachem Asia Ltd Chemical injection method
JP2013000678A (en) * 2011-06-17 2013-01-07 Miura Co Ltd Water treatment system
EP2681157A1 (en) * 2011-03-04 2014-01-08 Aquis Wasser-Luft-Systeme GmbH Lindau, Zweigniederlassung Rebstein Water conditioner for preventing or reducing mineral precipitation
JP2014161828A (en) * 2013-02-27 2014-09-08 Hazama Ando Corp Cleaning method and cleaning system of contaminated soil
JP2014199149A (en) * 2013-03-29 2014-10-23 栗田工業株式会社 Open circulation cooling facility and facility working detection device
JP2016193417A (en) * 2015-04-01 2016-11-17 栗田工業株式会社 Method and device for injecting chemical into open-type circulating cooling water system
JP2018038942A (en) * 2016-09-05 2018-03-15 三浦工業株式会社 Water treatment system

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005246172A (en) * 2004-03-02 2005-09-15 Permachem Asia Ltd Chemical injection method
EP2681157A1 (en) * 2011-03-04 2014-01-08 Aquis Wasser-Luft-Systeme GmbH Lindau, Zweigniederlassung Rebstein Water conditioner for preventing or reducing mineral precipitation
KR20140048858A (en) * 2011-03-04 2014-04-24 아쿠이스 바써-루프트-시스테메 게엠베하, 린다우, 쯔바이그니더라숭 렙슈타인 Water conditioner for preventing or reducing mineral precipitation
JP2014512941A (en) * 2011-03-04 2014-05-29 アクイス ヴァッサー−ルフト−ジステーメ ゲーエムベーハー, リンダウ,ツヴァイクニーダーラッスング レブシュタイン Water conditioning device for preventing or reducing mineral precipitation
KR101852650B1 (en) * 2011-03-04 2018-06-04 아쿠이스 바써-루프트-시스테메 게엠베하, 린다우, 쯔바이그니더라숭 렙슈타인 Water conditioner for preventing or reducing mineral precipitation
EP2681157B1 (en) * 2011-03-04 2019-12-18 Aquis Wasser-Luft-Systeme GmbH, Lindau, Zweigniederlassung Rebstein Water conditioner for preventing or reducing mineral precipitation
JP2013000678A (en) * 2011-06-17 2013-01-07 Miura Co Ltd Water treatment system
JP2014161828A (en) * 2013-02-27 2014-09-08 Hazama Ando Corp Cleaning method and cleaning system of contaminated soil
JP2014199149A (en) * 2013-03-29 2014-10-23 栗田工業株式会社 Open circulation cooling facility and facility working detection device
JP2016193417A (en) * 2015-04-01 2016-11-17 栗田工業株式会社 Method and device for injecting chemical into open-type circulating cooling water system
JP2018038942A (en) * 2016-09-05 2018-03-15 三浦工業株式会社 Water treatment system

Also Published As

Publication number Publication date
JP3759583B2 (en) 2006-03-29

Similar Documents

Publication Publication Date Title
US7208117B2 (en) Automated process for inhibiting corrosion in an inactive boiler containing an aqueous system
ES2741651T3 (en) Method and device to monitor and control the status of a process stream
JPS6320496A (en) Automated chlorine generator
JP2003154241A (en) Method and apparatus for dissolving solid chemical
TW200536624A (en) Circulated type gas-soluble water supplying device and the running method of said device
US7186373B2 (en) Visual detector for vaporized hydrogen peroxide
JP3427840B1 (en) Corrosion resistance test equipment
JP2021003262A (en) Dialysis waste fluid treatment system and dialysis waste fluid treatment
JP4139938B2 (en) Operation support system for soft water facilities
JP2005013788A (en) AIR CLEANER AND METHOD FOR CONTROLLING pH VALUE OF TREATING LIQUID
KR101281791B1 (en) A sterilization medicine auto provider
WO2020138300A1 (en) Ballast water treatment device
JP7284624B2 (en) Residual chlorine removal method, controller for residual chlorine removal system, and residual chlorine removal system
US7273561B1 (en) Method for determining the chemical dosage required to reduce sulfides in wastewater to acceptable levels
JP6645367B2 (en) Wastewater treatment method
JP2020195966A (en) Wastewater treatment system and wastewater treatment method
WO2024100922A1 (en) Hydrogen peroxide decomposition system, hydrogen peroxide decomposition device, and decomposition method for hydrogen peroxide
JP2001066090A (en) Method and apparatus for suppressing proliferation of microorganism in circulation cooling water
JP2009291693A (en) Concentration management method and apparatus of chemical for water treatment
JPH064168Y2 (en) Control device for chemical injection into boiler
KR100956810B1 (en) Water-treatment controlling system and the apparatus using orp sensor
JPH07190989A (en) Electrolytic water circulation characteristic detector
JPS59193339A (en) Testing apparatus of corrosive gas environment
CN217808789U (en) Circulating water treatment system and control device thereof
KR200404638Y1 (en) The antiseptic solution injectioning apparatus on measuring antiseptic solution concentration of the water

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20050421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050506

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050628

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20050722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20051216

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20051229

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3759583

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090113

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100113

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110113

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110113

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120113

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120113

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130113

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130113

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140113

Year of fee payment: 8

LAPS Cancellation because of no payment of annual fees